Results 91 to 100 of about 213,756 (228)

Effect of phospholipids on the structure of Triatoma infestans lipophorin studied by fluorescence methods

open access: yesJournal of Lipid Research, 1996
To study the role of phospholipids in the lipophorin structure, they were removed by phospholipase A2 treatment. Fluorescence lifetimes and accessibility to acrylamide quenching of different diphenylhexatrienyl derivatives, which were used as analogues ...
O J Rimoldi, H A Garda, R R Brenner
doaj  

Anti-phospholipase A2 receptor antibody in membranous nephropathy.

open access: yesJournal of the American Society of Nephrology, 2011
The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is unknown among Chinese patients with MN.
W. Qin   +7 more
semanticscholar   +1 more source

Contribution of Sympathetic Sensory Coupling to Craniofacial Nociception

open access: yesOrthodontics &Craniofacial Research, EarlyView.
ABSTRACT Stress and anxiety are associated with increased pain intensity in temporomandibular disorders (TMDs) patients. It is possible that this association is due to a direct interaction between the sympathetic and sensory nervous systems. This narrative review examines evidence for a potential sympathetic sensory interaction in deep craniofacial ...
Brian Edwin Cairns
wiley   +1 more source

Effect of adiposity status on salivary Streptococcus mutans and Streptococcus sobrinus

open access: yesOral Diseases, EarlyView.
Abstract Objectives To investigate the effect of adiposity status, salivary physicochemical parameters, and inflammatory biomarkers on the salivary abundance of the two main cariogenic bacteria Streptococcus mutans and Streptococcus sobrinus among Hong Kong adolescents. Subjects and Methods This study included 180 adolescents aged 12–15 years from Hong
Qianyi Deng, Hai Ming Wong, Simin Peng
wiley   +1 more source

Secreted phospholipase A2 and mast cells

open access: yesAllergology International, 2015
Phospholipase A2s (PLA2s) are a group of enzymes that hydrolyze the sn-2 position of phospholipids to release (typically unsaturated) fatty acids and lysophospholipids, which serve as precursors for a variety of bioactive lipid mediators.
Makoto Murakami, Yoshitaka Taketomi
doaj   +1 more source

Autoantibodies Specific for the Phospholipase A2 Receptor in Recurrent and De Novo Membranous Nephropathy

open access: yesAmerican Journal of Transplantation, 2011
Recent findings in idiopathic membranous nephropathy (MN) suggest that in most patients, the disease is because of anti‐phospholipase A2 receptor (PLA2R1) autoantibodies. Our aim was to analyze the prevalence and significance of anti‐PLA2R1 antibodies in
H. Dębiec   +12 more
semanticscholar   +1 more source

The Landscape of Cancer Metabolism as a Therapeutic Target

open access: yesPathology International, EarlyView.
ABSTRACT Cancer cells reprogram their metabolism during progression to adapt to the tumor microenvironment, which is characterized by distinct differences in nutrient availability, oxygen concentrations, and acidity. This metabolic reprogramming can simultaneously create metabolic vulnerabilities unique to cancer cells, making cancer metabolism a ...
Kenji Ohshima
wiley   +1 more source

Effect of probiotic supplementation on lipoprotein-associated phospholipase A2 in type 2 diabetic patients: a randomized double blind clinical controlled trial

open access: yesNutrition & Metabolism
Background It has been recently reported that lipoprotein-associated phospholipase A2 (Lp-PLA2) may predict the risk of cardiovascular disease. The effect of multi-strain probiotics on Lp-PLA2 in patients with type 2 diabetes is still not clear.
Salman Jaff   +3 more
doaj   +1 more source

Rheocarna treatment for non‐dialysis patients

open access: yesTherapeutic Apheresis and Dialysis, Volume 29, Issue 4, Page 588-592, August 2025.
Abstract Introduction Rheocarna has attracted attention as an alternative therapy for severe chronic limb‐threatening ischemia, and there have been reports of its usefulness. However, most of these reports have been on dialysis patients, and there are few reports on the treatment conditions and efficacy in non‐dialysis patients.
Atsushi Ohkubo   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy